Siegfried (SGFEF) Stock Price, News & Analysis

Company Overview

Siegfried Holding AG, together with its subsidiaries, provides contract development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms to the pharmaceutical industry worldwide. It offers pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale-up and clinical trial material production services. The company develops and produces APIs and intermediates, as well as finished dosage forms, including solid oral dosage forms, sterile and aseptic filling injectables, ophthalmics, and inhalative products. In addition, it provides APIs and controlled substances focusing on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition; exclusive synthesis services comprising process and chemical development, analytical development, pilot manufacturing and scale-up, and commercial manufacturing; and viral vector manufacturing solutions. Further, the company licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for products. Siegfried Holding AG was founded in 1873 and is headquartered in Zofingen, Switzerland.

Key Stats

• Today's Range: $114.35 to $114.35
• 50-Day Range: $102.50 to $114.35
• 52-Week Range: $114.35 to $1,025.00
• Volume: N/A
• Average Volume: 233 shs
• Market Capitalization: N/A
• P/E Ratio: 8.28
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Siegfried Stock Analysis - MarketRank™

Siegfried scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Siegfried.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Siegfried is 8.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.44.

Price to Earnings Ratio vs. Sector

The P/E ratio of Siegfried is 8.28, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.36.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Siegfried has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Siegfried has recently decreased by 10.29%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Siegfried does not currently pay a dividend.

Dividend Growth

Siegfried does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Siegfried has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Siegfried has recently decreased by 10.29%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.22

News Sentiment

Siegfried has a news sentiment score of 1.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Siegfried this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Siegfried insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 19.09% of the stock of Siegfried is held by institutions.

SGFEF Stock Analysis - Frequently Asked Questions

How have SGFEF shares performed this year?

Siegfried's stock was trading at $965.00 at the start of the year. Since then, SGFEF shares have decreased by 88.2% and is now trading at $114.35.

How do I buy shares of Siegfried?

Shares of SGFEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SGFEF
• CIK: N/A
• Web: www.siegfried.ch
• Phone: 41 62 746 1111
• Fax: N/A
• Employees: 3,819
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 8.28
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A